OBJECTIVE: A study in The Faroe Islands in 1995 suggested a high prevalence of idiopathic Parkinson's disease (IPD) and total parkinsonism of 187.6 and 233.4 per 100,000 inhabitants respectively. METHODS: Detailed case-finding methods 10 years later were used and a neurologist has verified the diagnosis. RESULTS: The crude prevalence of IPD and total parkinsonism was 206.7 per 100,000 and 227.4 per 100,000 respectively. The age-adjusted prevalence is twice as high as data from Norway and Denmark. Age at initiation of treatment and the fatality rate did not explain the increased prevalence. During 1995-2005, the average annual incidence was 21.1 per 100,000 persons for Parkinson's disease, and 22.9 per 100,000 persons, if including atypical parkinsonism. CONCLUSION: The high prevalence was verified and linked to a high incidence. The cause of the high prevalence is unknown, but neurotoxic contaminants in traditional food may play a role in the pathogenesis in this population, perhaps jointly with genetic predisposition.
OBJECTIVE: A study in The Faroe Islands in 1995 suggested a high prevalence of idiopathic Parkinson's disease (IPD) and total parkinsonism of 187.6 and 233.4 per 100,000 inhabitants respectively. METHODS: Detailed case-finding methods 10 years later were used and a neurologist has verified the diagnosis. RESULTS: The crude prevalence of IPD and total parkinsonism was 206.7 per 100,000 and 227.4 per 100,000 respectively. The age-adjusted prevalence is twice as high as data from Norway and Denmark. Age at initiation of treatment and the fatality rate did not explain the increased prevalence. During 1995-2005, the average annual incidence was 21.1 per 100,000 persons for Parkinson's disease, and 22.9 per 100,000 persons, if including atypical parkinsonism. CONCLUSION: The high prevalence was verified and linked to a high incidence. The cause of the high prevalence is unknown, but neurotoxic contaminants in traditional food may play a role in the pathogenesis in this population, perhaps jointly with genetic predisposition.
Authors: Eina H Eliasen; Monica Ferrer; Shahin Gaini; Elan D Louis; Maria Skaalum Petersen Journal: Neuroepidemiology Date: 2019-03-19 Impact factor: 3.282
Authors: Katrin D Apol; Leivur N Lydersen; Ólavur Mortensen; Pál Weihe; Bjarni Á Steig; Guðrið Andorsdóttir; Noomi O Gregersen Journal: Scand J Public Health Date: 2021-10-05 Impact factor: 3.199
Authors: Rosanna Squitti; G Gorgone; V Panetta; R Lucchini; S Bucossi; E Albini; L Alessio; A Alberici; J M Melgari; L Benussi; G Binetti; P M Rossini; F Draicchio Journal: J Neural Transm (Vienna) Date: 2009-08-14 Impact factor: 3.575
Authors: Karim Fifel; Julien Vezoli; Kwamivi Dzahini; Bruno Claustrat; Vincent Leviel; Henry Kennedy; Emmanuel Procyk; Ouria Dkhissi-Benyahya; Claude Gronfier; Howard M Cooper Journal: PLoS One Date: 2014-01-23 Impact factor: 3.240